Disulfide High-Mobility Group Box 1 Drives Ischemia-Reperfusion Injury in Human Liver Transplantation.
Rebecca A SosaAllyson Q TerryFady M KaldasYi-Ping JinMaura RossettiTakahiro ItoFang LiRichard S AhnBita V NainiVictoria M GroysbergYing ZhengAntony AzizJessica Nevarez-MejiaAli ZarrinparRonald W BusuttilDavid W GjertsonJerzy W Kupiec-WeglinskiElaine F ReedPublished in: Hepatology (Baltimore, Md.) (2020)
These data identify disulfide-HMGB1 as a mechanistic biomarker of, and therapeutic target for, minimizing sterile inflammation during human liver IRI.